Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM.
Leor ZachAmir AgamiOrit FurmanMoshe AttiaZvi CohenIris Ben-Bassat MizrachiGuy TamZion ZiblyOuzi NissimRoberto SpiegelmannRuth Huna-BaronPublished in: Radiation oncology (London, England) (2021)
Our findings, using comprehensive and meticulous investigation of visual outcomes, suggest that hSRT may be associated with higher risk for VA and VF deterioration in AVPM especially in ONSM. We recommend the use of cFSRT for ONSM.